DANISH Trial – ICD Subgroup Mortality Index
Educational summary of selected subgroup findings from the DANISH trial for primary-prevention ICD therapy in non-ischaemic systolic heart failure. Enter the patient profile to see whether it matches the age and NT-proBNP thresholds explored in subgroup analyses.
Patient profile
Complete all fields. CRT and NYHA class are recorded for context and do not alter the subgroup classification.
Clinical context and interpretation
The DANISH trial evaluated primary-prevention ICD implantation in patients with non-ischaemic systolic heart failure. In the main trial, ICD implantation did not significantly reduce all-cause mortality overall, although sudden cardiac death was reduced.
What the subgroup markers mean
- Age: a prespecified subgroup analysis reported an association between ICD and lower all-cause mortality in patients aged ≤70 years (HR 0.70, 95% CI 0.51–0.96), but not in older patients.
- NT-proBNP: in extended follow-up, the estimate below the median was HR 0.75 (95% CI 0.55–1.03); the interaction test was not statistically significant.
- CRT: CRT status is displayed as context only. It does not change this tool's classification.
Clinical use
This tool classifies whether entered values match two published subgroup cut points. It does not calculate absolute mortality risk, predict an individual treatment effect, or determine ICD eligibility. Decisions require current guideline criteria, expected survival, comorbidity, competing risks, patient preferences, and specialist assessment.
Key evidence
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.